Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus A Kuczyk

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Handbook of Experimental Pharmacology|February 4, 2011
Cyclic nucleotide metabolism including nitric oxide and phosphodiesterase-related targets in the lower urinary tractStefan Uckert, Markus A Kuczyk
Aktuelle Urologie|April 5, 2023
Markus A Kuczyk, Evangelista Martinelli
Current Opinion in Urology|September 1, 2007
The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgeryAxel S Merseburger, Markus A Kuczyk
World Journal of Urology|February 13, 2008
Changing concepts in the surgery of renal cell carcinomaAxel S Merseburger, Markus A Kuczyk
Expert Review of Clinical Pharmacology|May 10, 2013
Phosphodiesterase inhibitors in clinical urologyStefan Ückert, Markus A Kuczyk, Matthias Oelke
Der Urologe. Ausg. A|December 21, 2018
[Artificial intelligence and neural networks in urology]Christoph-Alexander J von Klot, Markus A Kuczyk
Current Opinion in Urology|August 2, 2008
Bladder preserving strategies for muscle-invasive bladder cancerAxel S Merseburger, Ira Matuschek, Markus A Kuczyk
Deutsches Arzteblatt International|June 10, 2010
Re: Male sexual dysfunction: diagnosis and treatment from a sexological and interdisciplinary perspective. Absence of desireMarkus A Kuczyk, Annika Simon, Axel Stuart Merseburger
World Journal of Urology|February 14, 2021
PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or bothHossein Tezval, Jan Hinrich Braesen, Markus A Kuczyk
World Journal of Urology|December 6, 2025
The significance of endocannabinoid receptors and endocannabinoids in the lower urinary and genital tractStefan Ückert, Petter Hedlund, Dimitrios Tsikas, et al.
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Handbook of Experimental Pharmacology|February 4, 2011
Cyclic nucleotide metabolism including nitric oxide and phosphodiesterase-related targets in the lower urinary tractStefan Uckert, Markus A Kuczyk
Aktuelle Urologie|April 5, 2023
Markus A Kuczyk, Evangelista Martinelli
Current Opinion in Urology|September 1, 2007
The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgeryAxel S Merseburger, Markus A Kuczyk
World Journal of Urology|February 13, 2008
Changing concepts in the surgery of renal cell carcinomaAxel S Merseburger, Markus A Kuczyk
Expert Review of Clinical Pharmacology|May 10, 2013
Phosphodiesterase inhibitors in clinical urologyStefan Ückert, Markus A Kuczyk, Matthias Oelke
Der Urologe. Ausg. A|December 21, 2018
[Artificial intelligence and neural networks in urology]Christoph-Alexander J von Klot, Markus A Kuczyk
Current Opinion in Urology|August 2, 2008
Bladder preserving strategies for muscle-invasive bladder cancerAxel S Merseburger, Ira Matuschek, Markus A Kuczyk
Deutsches Arzteblatt International|June 10, 2010
Re: Male sexual dysfunction: diagnosis and treatment from a sexological and interdisciplinary perspective. Absence of desireMarkus A Kuczyk, Annika Simon, Axel Stuart Merseburger
World Journal of Urology|February 14, 2021
PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or bothHossein Tezval, Jan Hinrich Braesen, Markus A Kuczyk
World Journal of Urology|December 6, 2025
The significance of endocannabinoid receptors and endocannabinoids in the lower urinary and genital tractStefan Ückert, Petter Hedlund, Dimitrios Tsikas, et al.
Pageof 21